Happiness Capital: Investment Portfolio & Startup News
Happiness Capital
To add a bio or update investment portfolio, please click update information.
Investment Portfolio
Epoch Biodesign
25 Mar 2026
Epoch Biodesign raises £9m in funding from lululemon and leading VCs for enzymatic nylon recycling
Epoch Biodesign develops enzymatic recycling technology that converts waste nylon materials back into their original chemical components. It enables manufacturers to produce new nylon without using virgin feedstock, helping apparel and automotive companies reduce reliance on raw materials.
Epoch Biodesign
5 Mar 2025
Epoch Biodesign raises £14m Series A led by Extantia Capital to scale plastic-eating enzyme technology
Epoch Biodesign uses engineered enzymes to break down plastic waste into reusable chemical building blocks, enabling higher-quality recycling at industrial scale.
Happiness Capital
- 1(12 months)
- happinesscapital.com
- Update Information
More venture news
- 30 Sept 2026
ZenithonZenithon raises a £7.5m seed round led by BACKED for ML models that solves complex physics
EquityDeep Tech - 30 Sept 2026
Inovus MedicalInovus Medical lands £7m extension led by PXN Group to provide surgeons with surgical simulation training
EquityHealth - 29 Sept 2026
Something & NothingSomething & Nothing unlocks £5m in funding led by Venrex for premium soft drinks built on flavour
EquityConsumer
